Skip to main content
. 2015 Jan 28;212(4):516–524. doi: 10.1093/infdis/jiv044

Table 3.

Prevalence of Healthcare Visits and Symptoms During Human Bocavirus 1 (HBoV-1) Primary and Recurrent Events, Compared With Matched Control Periods

Variable HBoV-1 Primary Event
HBoV-1 Primary Events, Peak Viral Load ≥6 Logs Only
HBoV-1 Recurrent Event
HBoV-1 Event, No. (%) (n= 66)a Control Period, No. (%) (n = 132)a OR (95% CI)b HBoV-1 High Copy Event, No. (%) (n = 36) Control Period, No. (%) (n = 72)a OR (95% CI)b First HBoV-1 Recurrence, n (%) (n = 33) Control Period,a No. (%) (n = 66) OR (95% CI)b
Healthcare visit 12 (18) 11 (8) 2.8 (1.02–7.7) 10 (28) 5 (7) 7.5 (1.6–34.8) 5 (15) 9 (14) 1 (.3–3.5)
Fever 17 (26) 20 (15) 2.1 (.9–4.6) 14 (39) 14 (20) 2.5 (1.0–6.1) 9 (27) 9 (14) 3.0 (.9–10.4)
New rhinorrhea 31 (47) 44 (33) 1.7 (.9–3.2) 23 (64) 24 (34) 2.9 (1.3–6.7) 13 (39) 22 (34) 0.9 (.4–2.4)
New cough 29 (44) 32 (24) 2.7 (1.4–5.5) 20 (56) 17 (24) 4.1 (1.6–10.7) 15 (45) 26 (41) 1.6 (.6–4.2)
Vomiting 3 (5) 12 (9) 0.5 (.1–1.7) 2 (6) 9 (13) 0.4 (.08–1.9) 1 (3) 5 (8) 0.3 (.04–3.4)
Diarrhea 4 (6) 9 (7) 0.8 (.2–3.2) 3 (8) 7 (10) 0.7 (.1–3.7) 3 (9) 6 (9) 1.0 (.2–6.4)
General rash 3 (5) 5 (4) 1.2 (.3–5.0) 1 (3) 3 (4) 0.7 (.07–6.4) 2 (6) 4 (6) 1.0 (.2–6.4)
Local rash 1 (2) 2 (2) 1.0 (.09–11.0) 1 (3) 1 (1) 2.0 (.1–32.0) 1 (3) 2 (3) 1.0 (.1–11.0)
Fussiness 25 (38) 44 (33) 1.2 (.6–2.5) 17 (47) 22 (31) 2.0 (.9–4.8) 12 (36) 23 (36) 1.0 (.4–2.7)
New respiratory symptomc 41 (62) 54 (41) 2.3 (1.2–4.2) 30 (83) 29 (41) 5.6 (2.1–15.1) 20 (61) 38 (59) 1.0 (.4–2.5)

Abbreviations: CI, confidence interval; OR, odds ratio.

a Symptom data missing for 2 of 132 control periods, 2 of 72 high-copy control periods, 2 of 66 recurrence control periods, and 1 of 66 primary case events. The valid percentage is reported.

b The OR was calculated using conditional logistic regression, to account for correlation in case and control periods matched by individual child.

c Defined as new-onset cough and/or new-onset rhinorrhea.